Ampersand Capital Partners Overview
- Investor Type
- Growth/Expansion
- Status
- Active
- Professionals
- 23
- Investments
- 172
- Portfolio
- 19
- Exits
- 86
Ampersand Capital Partners General Information
Description
Founded in 1988, Ampersand Capital Partners is a private equity firm based in Wellesley, Massachusetts. The firm prefers to be the first institutional investor and focuses on EBITDA-positive lower middle-market healthcare companies that provide products and services within several key healthcare sectors, including laboratory testing services, laboratory products, contract manufacturing, pharma services, specialty pharma, and healthcare services.
Contact Information
Website
www.ampersandcapital.com
Year Founded
1988
Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Other Investor Types
PE/Buyout
Venture Capital
Primary Office
- 55 William Street
- Suite 240
- Wellesley, MA 02481
- United States
+1 (781) 000-0000
Ampersand Capital Partners Investments & Acquisitions (172)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 0000000 | 01-Mar-2022 | 00 000000000 | Medical Supplies | Generating Revenue | 00000 000000 00.0 | |
| 0000 00000000000 | 15-Dec-2021 | 0000000000 | Laboratory Services (Healthcare) | Generating Revenue | ||
| 000 00000000000000 | 22-Nov-2021 | 0000 | 0000 | Pharmaceuticals | Generating Revenue/Not Profitable | |
| 000000 00000000000 | 17-Nov-2021 | 0000000000 | Biotechnology | Generating Revenue | 00000 000000 00.0 | |
| Alliance Pharma (United States) | 04-Nov-2021 | Buyout/LBO | Pharmaceuticals | Generating Revenue | 00000 00000000 |
Ampersand Capital Partners Exits (86)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 0000000000 | 18-Feb-2022 | 0000000000 | |
| 000000000 0000000 | 05-Jan-2022 | 0000000000 | |
| 0000000 | 05-Jan-2022 | 000000000000000000 | |
| 0000000 000000000 | 20-Dec-2021 | 000000000000000000 | 00000 |
| N2 Biomedical | 20-Sep-2021 | Merger/Acquisition |
Ampersand Capital Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Ampersand Capital Partners‘s full profile, request access.
Request a free trialAmpersand Capital Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAmpersand Capital Partners Team (47)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Dana Niles | Partner & Chief Operating Officer | Wellesley, MA | |||
| Richard Charpie Ph.D | Founder & Managing Partner | 00 | 0 | 0 | Wellesley, MA |
| Herbert Hooper Ph.D | Managing Partner | 00 | 0 | 0 | Wellesley, MA |
| David Anderson Ph.D | General Partner | 00 | 0 | 0 | Wellesley, MA |
| David Parker | General Partner | 00 | 0 | 0 | Amsterdam, Netherlands |